UXIN
Uxin Ltd
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
uxin group is china's largest online used car transaction platform. uxin offers b2b, b2c and c2b services through two main brands uxin auction (优信拍) and uxin used car (优信二手车). by creating a nationwide, data-enabled supply chain and increasing transparency in the transaction process, uxin is increasing efficiency and strengthening trust in china's used car industry. its efforts have already been recognized by international investment firms and leading tech companies, who have invested over $1 billion in the company.
Market Cap: 945 Million
Primary Exchange: NASDAQ
Shares Outstanding: 459 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.6237649641573624
Sector: Information
Industry: Software Publishers
Ethical Flags
Longest drawdown: 880 trading days
From: 2018-06-28 To: 2024-03-07
Lowest Point:
Uxin Limited (UXIN) CEO Kun Dai on Q1 2019 Results - Earnings Call Transcript
via: SeekingAlpha at 2019-06-10 11:19:06:000
Uxin Limited. (UXIN) Q1 2019 Results Earnings Conference Call June 10, 2019, 08:00 AM ET Company Participants Nancy Song - Investor Relations, Director Kun Dai - Founder, Chairman & Chief Executive Officer Zhen Zeng - Chief Financial Officer & Director Michael Yao - C… read more...
Uxin Limited (UXIN) CEO Kun Dai on Q1 2019 Results - Earnings Call Transcript
via: SeekingAlpha at 2019-06-10 11:19:06:000
Uxin Limited. (UXIN) Q1 2019 Results Earnings Conference Call June 10, 2019, 08:00 AM ET Company Participants Nancy Song - Investor Relations, Director Kun Dai - Founder, Chairman & Chief Executive Officer Zhen Zeng - Chief Financial Officer & Director Michael Yao - C… read more...
Uxin Limited (UXIN) CEO Kun Dai on Q1 2019 Results - Earnings Call Transcript
via: SeekingAlpha at 2019-06-10 11:19:06:000
Uxin Limited. (UXIN) Q1 2019 Results Earnings Conference Call June 10, 2019, 08:00 AM ET Company Participants Nancy Song - Investor Relations, Director Kun Dai - Founder, Chairman & Chief Executive Officer Zhen Zeng - Chief Financial Officer & Director Michael Yao - C… read more...
Tracking Chase Coleman's Tiger Global Portfolio - Q1 2019 Update
via: SeekingAlpha at 2019-06-10 09:19:09:000
This article is part of a series that provides an ongoing analysis of the changes made to Chase Coleman's Tiger Global Management 13F stock portfolio on a quarterly basis. It is based on Tiger Global's regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Chase Coleman's Tiger … read more...
Tracking Chase Coleman's Tiger Global Portfolio - Q1 2019 Update
via: SeekingAlpha at 2019-06-10 09:19:09:000
This article is part of a series that provides an ongoing analysis of the changes made to Chase Coleman's Tiger Global Management 13F stock portfolio on a quarterly basis. It is based on Tiger Global's regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Chase Coleman's Tiger … read more...
Tracking Chase Coleman's Tiger Global Portfolio - Q1 2019 Update
via: SeekingAlpha at 2019-06-10 09:19:09:000
This article is part of a series that provides an ongoing analysis of the changes made to Chase Coleman's Tiger Global Management 13F stock portfolio on a quarterly basis. It is based on Tiger Global's regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Chase Coleman's Tiger … read more...
MNKD, DATA among premarket gainers
via: SeekingAlpha at 2019-06-10 05:13:59:000
Provention Bio (NASDAQ: PRVB ) +170% on potential of teplizumab to delay diabetes. More news on: Provention Bio, Inc., Tableau Software, Inc., Tilray, Inc., Stocks on the move, Read more … read more...
MNKD, DATA among premarket gainers
via: SeekingAlpha at 2019-06-10 05:13:59:000
Provention Bio (NASDAQ: PRVB ) +170% on potential of teplizumab to delay diabetes. More news on: Provention Bio, Inc., Tableau Software, Inc., Tilray, Inc., Stocks on the move, Read more … read more...
MNKD, DATA among premarket gainers
via: SeekingAlpha at 2019-06-10 05:13:59:000
Provention Bio (NASDAQ: PRVB ) +170% on potential of teplizumab to delay diabetes. More news on: Provention Bio, Inc., Tableau Software, Inc., Tilray, Inc., Stocks on the move, Read more … read more...
Uxin reports Q1 results
via: SeekingAlpha at 2019-06-10 01:32:47:000
Uxin (NASDAQ: UXIN ): Q1 GAAP EPS of -RMB0.32. More news on: Uxin Limited, Earnings news and commentary, Tech stocks news, Read more … read more...
Uxin reports Q1 results
via: SeekingAlpha at 2019-06-10 01:32:47:000
Uxin (NASDAQ: UXIN ): Q1 GAAP EPS of -RMB0.32. More news on: Uxin Limited, Earnings news and commentary, Tech stocks news, Read more … read more...
Uxin reports Q1 results
via: SeekingAlpha at 2019-06-10 01:32:47:000
Uxin (NASDAQ: UXIN ): Q1 GAAP EPS of -RMB0.32. More news on: Uxin Limited, Earnings news and commentary, Tech stocks news, Read more … read more...
Uxin: It Is A Buy At 1.5x Forward Sales
via: SeekingAlpha at 2019-06-09 14:01:59:000
After massive erosion in its valuation, Uxin ( UXIN ) is selling at 1.5x forward sales. With 69% revenue growth and an asset/liability ratio of 1.6x, the company represents a buying opportunity. Bilbao Asset Management was correct when it noted that the company could not sell ADSs at $10.50-… read more...
Notable earnings before Monday's open
via: SeekingAlpha at 2019-06-09 13:30:58:000
LOVE , THO , UXIN For Seeking Alpha's full earnings season calendar, click here . More news on: The Lovesac Company, Thor Industries, Inc., Uxin Limited, Earnings news and commentary, read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|